EKARNIA

What this means for you

Not registered yet, but its 06 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79426137

Mark type

Stylized text

Filed

06 Feb 2025

Attorney of record

Jonathan A. Hyman

Goods and services

• Class 035 — Advertising and business services: Advertising services; marketing services; market research; provision of business information; data processing services; compilation of business data; business intelligence services; business and commercial information provided by access to a computer database; business performance measurement, assessment, review and monitoring, namely, business management and consultancy services; provision of supplier, vendor, contractor, agency or supply chain information, including sourcing, tender selection and processing requests for information (RFI), namely, providing business and commercial information; provision of performance feedback about suppliers, vendors, contractors, agencies or businesses in the supply chain; review of suppliers, vendors, contractors or the supply chain through business assessment services, namely, providing independent ratings and reviews of other businesses for commercial purposes; outsourcing services; compilation of business data about suppliers, vendors, contractors and agencies; business consulting services, namely, providing assistance in development of creative ideation; all relating to businesses in the pharmaceutical and biotech industries; consultancy, advisory and information services relating to the above services
• Class 042 — Scientific and technological services: Hosting of third party content, photos, text, data, images, web sites and other electronic works, namely, hosting of information, including datasheets, fact sheets, leaflets, brochures, supplier information, all relating to suppliers within the pharmaceutical industry; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for sourcing suppliers and service providers in the pharmaceutical industry through research, analysis and comparison, and making connections with pharmaceutical suppliers; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for sourcing suppliers and service providers; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for sourcing goods, managing vendor communications, generating quote comparisons, and managing supply chains and supply chain procurement; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for generating supplier data for purchasing; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for supply chain management; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for supplier operational risk management; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for supplier identification, supplier fact sheet creation, supply chain analysis and sourcing software for procurement; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for sourcing suppliers and service providers in the pharmaceutical industry through research, analysis and comparison, and making connections with pharmaceutical suppliers; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for sourcing suppliers and service providers; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for sourcing goods, managing vendor communications, generating quote comparisons, and managing supply chains and supply chain procurement; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for generating supplier data for purchasing; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for supply chain management; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for supplier operational risk management; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for supplier identification, supplier fact sheet creation, supply chain analysis and sourcing software for procurement; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for sourcing suppliers and service providers in the pharmaceutical industry through research, analysis and comparison, and making connections with pharmaceutical suppliers; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for sourcing suppliers and service providers; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for sourcing goods, managing vendor communications, generating quote comparisons, and managing supply chains and supply chain procurement; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for generating supplier data for purchasing; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for supply chain management; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for supplier operational risk management; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for supplier identification, supplier fact sheet creation, supply chain analysis and sourcing software for procurement; Software platform services, namely, platform as a service (PaaS) featuring artificial intelligence software for sourcing suppliers and service providers in the pharmaceutical industry through research, analysis and comparison, and making connections with pharmaceutical suppliers; pharmaceutical research and development services; biotech research and development services; consultancy pertaining to pharmacology; providing information relating to scientific research in the fields of biochemistry and biotechnology; preparation of reports in the biotechnology field, namely, information relating to pharmaceutical suppliers and information relating to therapy area, location and size; consultancy, advisory and information services relating to the above services

Owner

• Limelight Health Ltd, GB

Prosecution history

• 17 Mar 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 17 Mar 2026 — FINAL REFUSAL E-MAILED
• 17 Mar 2026 — FINAL REFUSAL WRITTEN
• 24 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 23 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 23 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 12 Sept 2025 — REFUSAL PROCESSED BY IB
• 26 Aug 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 26 Aug 2025 — REFUSAL PROCESSED BY MPU
• 22 Jul 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 21 Jul 2025 — NON-FINAL ACTION WRITTEN
• 18 Jul 2025 — NEW REPRESENTATIVE AT IB RECEIVED
• 16 Jul 2025 — ASSIGNED TO EXAMINER
• 23 Jun 2025 — APPLICATION FILING RECEIPT MAILED
• 23 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED